Metabolomic and proteomic analysis of breast cancer patient samples suggests that glutamate and 12-HETE in combination with CA15-3 may be useful biomarkers reflecting tumour burden

by Cyrus Huneycutt | Nov 14, 2023 | 0 comments

Submit a Comment Cancel reply

You must be logged in to post a comment.